Targeting final FDA approval of YUTREPIA™ after expiration of regulatory exclusivity on May 23, 2025Advancing pipeline of inhaled treprostinil ...

When it comes to recipes, I have a few nonnegotiables: simple, healthy and delicious! These creations are terrific for when you’re craving a quick breakfast or scrumptious afternoon snack: my ...

An icon of 3 horizontal dots. An icon of a paper envelope. An icon of a facebook f logo. An icon of a digital camera. An icon of a house. An icon of the Instagram logo. An icon of the LinkedIn logo.

DPI stands for Dots Per Inch. It is used to represent the screen or display resolution. You can know your laptop screen’s or monitor’s DPI in the Display settings. The Surface Pro display is ...

The company offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat ...

WASHINGTON (AP) — With a push from President Donald Trump, House Republicans sent a GOP budget blueprint to passage Tuesday, a step toward delivering his “big, beautiful bill” with $4.5 ...

Despite the unfavorable ruling for Liquidia, the regulatory exclusivity period for Tyvaso DPI is still set to expire on May 23, 2025. Additionally, United Therapeutics had filed a cross claim in the ...

The US Food and Drug Administration’s decision to grant UTC three years of exclusivity for Tyvaso DPI was proper and Liquidia’s rival treatment fell within the scope of that exclusivity, Judge Timothy ...